Stage IIIB Breast Cancer Recruiting Phase 2 Trials for Neratinib (DB11828)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs